Country of origin: USA
Established: 1995 (part of Boston Scientific since 2015)
Focus: Minimally invasive treatment of pulmonary embolism and deep vein thrombosis

About the brand
EKOS Corporation was the first company in the world to introduce ultrasound-assisted thrombolysis (USAT) technology. This method enables targeted and effective clot dissolution using lower doses of thrombolytics, reducing the risk of complications.

Since 2015, EKOS has been part of Boston Scientific. The EKOS system is clinically proven and globally recognized for the treatment of acute pulmonary embolism (PE), deep vein thrombosis (DVT), and peripheral arterial occlusions.

Distributed in the Czech Republic and Slovakia

  • EKOS Endovascular System for ultrasound-assisted thrombolysis

More about the manufacturer: www.ekoscorp.com

▲